As part of the initial closing, Biomet has acquired DePuy’s trauma operations in the United States, the United Kingdom, Australia, New Zealand and Japan, as well as DePuy Trauma’s manufacturing operations in Le Locle, Switzerland. Closings for the remaining countries will occur on a staggered basis within the next six months. DePuy Orthopaedics’ affiliates will serve as Biomet’s interim distributor in these countries until these country operations are fully transitioned to Biomet.
Related Articles on Biomet:
FTC Approves Johnson & Johnson’s $21.3B Acquisition of Synthes
20 Orthopedic Device Company Q1 Financial Report Updates
17 Spine Devices Receive FDA 510(k) Clearance in March
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.